Sulzer to start trials on bone growth protein:
This article was originally published in Clinica
Executive Summary
Sulzer Medica will begin US clinical trials to examine whether its bone growth protein can repair bone loss associated with periodontal disease. Consisting of a mixture of naturally occurring bone growth factors in a collagen matrix, Ne-Osteo, a bone morphogenic protein (BMP), promotes bone growth. Sulzer Orthopedics Biologics is working with Sulzer Calcitek to develop applications of the Ne-Osteo BMP technology for dental use. Sulzer expects its market in dentistry to grow to $300 million within the next ten years.